Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo

OBJECTIVE: Carcinosarcoma is a deadly gynecologic malignancy with few effective treatment options. The study of new therapies is difficult because of its rarity. The objective of this study was to determine the efficacy of neratinib in the treatment of HER2 amplified carcinosarcoma. METHODS: The eff...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Gynecol Oncol
Κύριοι συγγραφείς: Schwab, Carlton L., English, Diana P., Black, Jonathan, Bellone, Stefania, Lopez, Salvatore, Cocco, Emiliano, Bonazzoli, Elena, Bussi, Beatrice, Predolini, Federica, Ferrari, Francesca, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Rutherford, Thomas, Schwartz, Peter E., Santin, Alessandro D.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2015
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587290/
https://ncbi.nlm.nih.gov/pubmed/26260909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2015.08.002
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια